HD White

1.7k total citations
51 papers, 1.2k citations indexed

About

HD White is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, HD White has authored 51 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cardiology and Cardiovascular Medicine, 15 papers in Surgery and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in HD White's work include Acute Myocardial Infarction Research (25 papers), Cardiac Imaging and Diagnostics (11 papers) and Atrial Fibrillation Management and Outcomes (10 papers). HD White is often cited by papers focused on Acute Myocardial Infarction Research (25 papers), Cardiac Imaging and Diagnostics (11 papers) and Atrial Fibrillation Management and Outcomes (10 papers). HD White collaborates with scholars based in New Zealand, United States and United Kingdom. HD White's co-authors include Joseph S. Alpert, Kristian Thygesen, Jeffrey W. Moses, Gregg W. Stone, Antonio Colombo, R. Mehran, James H. Ware, S J Pocock, Eugenia Nikolsky and Tim Clayton and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

HD White

46 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
HD White New Zealand 12 1.1k 394 344 175 100 51 1.2k
Carolyn H. McCabe United States 16 1.1k 1.0× 420 1.1× 396 1.2× 152 0.9× 63 0.6× 21 1.3k
Petr Widimský Czechia 17 1.2k 1.1× 560 1.4× 220 0.6× 231 1.3× 74 0.7× 36 1.3k
Francesco Chiarella Italy 20 1.4k 1.3× 409 1.0× 428 1.2× 85 0.5× 96 1.0× 61 1.6k
Herbert De Raedt Belgium 12 849 0.8× 408 1.0× 348 1.0× 51 0.3× 48 0.5× 24 1.1k
Sema Güneri Türkiye 15 572 0.5× 286 0.7× 121 0.4× 161 0.9× 88 0.9× 53 946
M. T. Roe United States 12 704 0.7× 458 1.2× 135 0.4× 106 0.6× 85 0.8× 20 941
Axel de Labriolle United States 19 1.3k 1.2× 759 1.9× 305 0.9× 338 1.9× 197 2.0× 54 1.6k
Heinz Joachim Buettner Germany 19 771 0.7× 617 1.6× 462 1.3× 70 0.4× 246 2.5× 37 1.5k
Menko Jan de Boer Netherlands 11 1.2k 1.2× 747 1.9× 676 2.0× 84 0.5× 88 0.9× 21 1.5k
E. Gijs Mast Netherlands 16 1.0k 1.0× 640 1.6× 498 1.4× 69 0.4× 224 2.2× 30 1.3k

Countries citing papers authored by HD White

Since Specialization
Citations

This map shows the geographic impact of HD White's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by HD White with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites HD White more than expected).

Fields of papers citing papers by HD White

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by HD White. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by HD White. The network helps show where HD White may publish in the future.

Co-authorship network of co-authors of HD White

This figure shows the co-authorship network connecting the top 25 collaborators of HD White. A scholar is included among the top collaborators of HD White based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with HD White. HD White is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
White, HD, et al.. (2012). Consensus statement on the use of high sensitivity cardiac troponins. The Egyptian Heart Journal. 9(3). 210–215. 6 indexed citations
2.
4.
White, HD, et al.. (2007). One-year outcome following outpatient parenteral antibiotic therapy (OPAT) treated bone and joint infections. Journal of Infection. 55(3). e79–e80. 1 indexed citations
5.
Montalescot, Gilles, Steven R. Steinhubl, Walter Desmet, et al.. (2006). Lack of correlation between ACT levels and outcomes in patients undergoing elective percutaneous coronary intervention with unfractionated heparin: the STEEPLE trial. European Heart Journal. 27. 645–645. 1 indexed citations
6.
Kenchaiah, Satish, Karl Swedberg, HD White, et al.. (2004). Modifiable Risk Factors for Stroke in High-Risk Patients following Acute Myocardial Infarction: Insights from the VALIANT Study. Circulation. 110(17).
7.
Ohman, E. Magnus, Neal S. Kleiman, HD White, et al.. (2001). Optimal dosing of a glycoprotein IIb/IIIa antagonist with simplified renal-based algorithm: pharmacodynamic and clinical findings from PARAGON B. Journal of the American College of Cardiology. 37(2).
8.
Kirby, Adrienne, David Hunt, Michael R. West, et al.. (2001). Pravastatin reduces the high rate of atherothrombotic complications in coronary heart disease patients with intermittent claudication. Journal of the American College of Cardiology. 37(2). 1 indexed citations
9.
Harrington, RA, et al.. (2001). Diabetes doubles the risk of death among patients presenting with acute coronary syndromes: insights from SYMPHONY, a large international trial. Journal of the American College of Cardiology. 37(2). 1 indexed citations
10.
Alexander, John H., et al.. (2000). Higher aPTTs associated with worse outcomes after thrombolytic therapy with reduced-dose heparin: results from Assent-2. Journal of the American College of Cardiology. 35(2). 2 indexed citations
11.
Topol, Eric J., et al.. (2000). Hirudin Significantly Reduces Ischemic Events Following Coronary Intervention for Acute Coronary Syndromes. Journal of the American College of Cardiology. 35(2). 2 indexed citations
12.
White, HD, R. John Simes, Ann Kirby, et al.. (1999). Predictors of stroke in patients with coronary heart disease in the LIPID study. Circulation. 100(18). 182–182. 20 indexed citations
13.
Anderson, R. David, HD White, E. Magnus Ohman, et al.. (1998). Resolution of ST-segment elevation 90 minutes after thrombolysis for acute myocardial infarction predicts outcome: a GUSTO-III substudy. Journal of the American College of Cardiology. 31. 371–371. 6 indexed citations
14.
Alexander, John H., et al.. (1997). Relationship of Outcomes to Treatment with Lamifiban in Patients Undergoing PTCA: Analysis of PARAGON A. Journal of the American College of Cardiology. 29. 3 indexed citations
15.
Harrington, RA, et al.. (1997). Combining IIb/IIIa Inhibition and Heparin for Acute Coronary Syndromes: Evidence of a Gradient for Bleeding Hazard from the PARAGON Randomized Factorially Designed Trial. Journal of the American College of Cardiology. 29. 2 indexed citations
16.
Col, J., J Boland, J. Dens, et al.. (1996). Determinants of mortality when primary LV failure complicates acute myocardial infarction. Intensive Care Medicine. 22(S1). S89–S89.
17.
White, HD, et al.. (1994). Functional Status Following Stroke After Thrombolytic Therapy - Results From the GUSTO Trial. Journal of the American College of Cardiology. 23. 1 indexed citations
18.
Théroux, Pierre, HD White, Daniel David, et al.. (1994). A heparin-controlled study of MK-383 in unstable angina. Circulation. 90(4). 18 indexed citations
19.
White, HD, et al.. (1991). Pre infarct angina pectoris predicts worse outcome in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gathered in the International TPA/SK Study. European Heart Journal. 12. 97–97. 1 indexed citations
20.
White, HD, et al.. (1986). Improved left ventricular function and early survival with intravenous streptokinase a double blind trial. 124. 5. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026